A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

NCT06209203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Epithelium Defect

Interventions

DRUG: lowe-dose ZKY001 eye drops
DRUG: Medium-dose ZKY001 eye drops
DRUG: placebo

Sponsor

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.